Technology
Innovative Scalable Conjugation Technology: Hydrazide-PEG-Hydrazide for Broad-Spectrum Vaccine Development
Our proprietary scalable conjugation technology, based on the bi-functional Hydrazide-PEG-Hydrazide linker, is designed to create highly immunogenic and broad-spectrum conjugate vaccines, offering enhanced efficacy and versatility in vaccine development.
Carrier Protein Formulation
Carrier protein formulation is a critical component in the development of effective vaccines and therapeutic products. We specialize in optimizing the formulation of carrier proteins to enhance their ability to elicit robust immune responses. By carefully selecting and modifying carrier proteins, we ensure improved stability, bioavailability, and compatibility with antigens. Our expertise in this area allows us to create formulations that maximize the immunogenic potential of conjugate vaccines, providing a solid foundation for innovative treatments. With a focus on precision and quality, we deliver carrier protein formulations tailored to meet the specific needs of each project, ultimately advancing the efficacy and success of our clients’ therapeutic endeavors.
Linkage
We focus on developing robust linkage strategies that facilitate the attachment of bioactive molecules to carrier proteins, improving their stability and bioavailability. By employing innovative techniques and optimized conditions, we ensure that the linked components maintain their functional integrity and bioactivity. This meticulous approach enables us to create conjugates that elicit strong immune responses and achieve targeted therapeutic outcomes, ultimately contributing to the advancement of more effective and safe treatments.
Heat-Stable Formulation
Heat-stable formulation is essential for ensuring the viability and effectiveness of vaccines and biopharmaceuticals in challenging storage and transport conditions. We specialize in developing heat-stable formulations that maintain the stability and potency of active ingredients, even in elevated temperatures. By employing advanced stabilization techniques, such as lyophilization and the use of excipients that enhance thermal resilience, we create formulations that are less susceptible to degradation. This focus on heat stability not only extends the shelf life of our products but also enables easier distribution and access to critical therapies, especially in regions with limited refrigeration infrastructure. Our commitment to innovation in heat-stable formulation supports the global effort to deliver safe and effective vaccines and therapeutics to populations in need.